Macrophage lineage phenotypes and osteoclastogenesis-Complexity in the control by GM-CSF and TGF-β

Bone

Volumn 40, Issue 2, 2007, Pages 323-336

  Lari, Roya ^a   Fleetwood, Andrew J ^a   Kitchener, Peter D ^a   Cook, Andrew D ^a   Pavasovic, Durda ^b   Hertzog, Paul J ^b   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Bone; c fos; Cell density; Cell number; Cytokines; Inflammation; Interferon; Osteoclast; Transforming growth factor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; GENE EXPRESSION; INFLAMMATION; INTERFERON PRODUCTION; MACROPHAGE; MOUSE; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PROTEIN FUNCTION; STEM CELL;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-ALPHA; INTERFERON-BETA; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; RANK LIGAND; RECOMBINANT PROTEINS; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33846000270     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.09.003     Document Type: Article

References (74)

1. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 (1997) 175-179
2. Burgess A.W., and Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56 (1980) 947-958
3. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., and Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161 (1998) 3639-3644
4. Cecchini MG, Hofstetter W, Halasy J, Wetterwald A, Felix R. Role of CSF-1 in bone and bone marrow development. Mol Reprod Dev 46: 75-83; discussion 83-4; 1997.
5. Celada A., and Maki R.A. Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. J. Immunol. 148 (1992) 1102-1105
6. Chambers T.J. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192 (2000) 4-13
7. Chan J., Leenen P.J., Bertoncello I., Nishikawa S.I., and Hamilton J.A. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92 (1998) 1423-1431
8. Cook A.D., Braine E.L., Campbell I.K., Rich M.J., and Hamilton J.A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3 (2001) 293-298
9. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7 (2006) 33-39
10. Filvaroff E., Erlebacher A., Ye J., Gitelman S.E., Lotz J., Heillman M., et al. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development (Cambridge, England) 126 (1999) 4267-4279
11. Fox S.W., and Lovibond A.C. Current insights into the role of transforming growth factor-beta in bone resorption. Mol. Cell Endocrinol. 243 (2005) 19-26
12. Fuller K., Kirstein B., and Chambers T.J. Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147 (2006) 1979-1985
13. Fuller K., Lean J.M., Bayley K.E., Wani M.R., and Chambers T.J. A role for TGFbeta(1) in osteoclast differentiation and survival. J. Cell Sci. 113 Pt 13 (2000) 2445-2453
14. Fuller K., Wong B., Fox S., Choi Y., and Chambers T.J. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188 (1998) 997-1001
15. Gorny G., Shaw A., and Oursler M.J. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Exp. Cell Res. 294 (2004) 149-158
16. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 (1994) 443-448
17. Hamilton J.A. CSF-1 and cell cycle control in macrophages. Mol. Reprod. Dev. 46 (1997) 19-23
18. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23 (2002) 403-408
19. Hamilton J.A., Vairo G., Nicola N.A., Burgess A., Metcalf D., and Lingelbach S.R. Activation and proliferation signals in murine macrophages: synergistic interactions between the hematopoietic growth factors and with phorbol ester for DNA synthesis. Blood 71 (1988) 1574-1580
20. Hamilton J.A., Whitty G.A., Kola I., and Hertzog P.J. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha. J. Immunol. 156 (1996) 2553-2557
21. Hodge J.M., Kirkland M.A., Aitken C.J., Waugh C.M., Myers D.E., Lopez C.M., et al. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF. J. Bone Miner. Res. 19 (2004) 190-199
22. Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J. Clin. Invest. 101 (1998) 595-603
23. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
24. Itonaga I., Sabokbar A., Sun S.G., Kudo O., Danks L., Ferguson D., et al. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 34 (2004) 57-64
25. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-beta1 to the bone. Endocr. Rev. 26 (2005) 743-774
26. Kaneda T., Nojima T., Nakagawa M., Ogasawara A., Kaneko H., Sato T., et al. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J. Immunol. 165 (2000) 4254-4263
27. Karsdal M.A., Hjorth P., Henriksen K., Kirkegaard T., Nielsen K.L., Lou H., et al. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J. Biol. Chem. 278 (2003) 44975-44987
28. Karst M., Gorny G., Galvin R.J., and Oursler M.J. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J. Cell Physiol. 200 (2004) 99-106
29. Kim M.S., Day C.J., and Morrison N.A. MCP-1 is induced by RANKL, promotes osteoclast fusion and rescues GM-CSF suppression of osteoclast formation. J. Biol. Chem. 280 (2005) 16163-16169
30. Koseki T., Gao Y., Okahashi N., Murase Y., Tsujisawa T., Sato T., et al. Role of TGF-beta family in osteoclastogenesis induced by RANKL. Cell. Signal. 14 (2002) 31-36
31. Kurihara N., Suda T., Miura Y., Nakauchi H., Kodama H., Hiura K., et al. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74 (1989) 1295-1302
32. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
33. Lagasse E., and Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89 (1997) 1021-1031
34. Leenen P.J., de Bruijn M.F., Voerman J.S., Campbell P.A., and van Ewijk W. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174 (1994) 5-19
35. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
36. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
37. Massey H.M., Scopes J., Horton M.A., and Flanagan A.M. Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 28 (2001) 577-582
38. Masurier C., Pioche-Durieu C., Colombo B.M., Lacave R., Lemoine F.M., Klatzmann D., et al. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy. Immunology 96 (1999) 569-577
39. Matsuzaki K., Udagawa N., Takahashi N., Yamaguchi K., Yasuda H., Shima N., et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246 (1998) 199-204
40. Menaa C., Kurihara N., and Roodman G.D. CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem. Biophys. Res. Commun. 267 (2000) 943-946
41. Miyamoto T., Arai F., Ohneda O., Takagi K., Anderson D.M., and Suda T. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 96 (2000) 4335-4343
42. Miyamoto T., Ohneda O., Arai F., Iwamoto K., Okada S., Takagi K., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98 (2001) 2544-2554
43. Miyamoto T., and Suda T. Differentiation and function of osteoclasts. Keio J. Med. 52 (2003) 1-7
44. Myint Y.Y., Miyakawa K., Naito M., Shultz L.D., Oike Y., Yamamura K., et al. Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. Am. J. Pathol. 154 (1999) 553-566
45. Orcel P., Bielakoff J., and De Vernejoul M.C. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures. J. Cell Physiol. 142 (1990) 293-298
46. Paine III R., Morris S.B., Jin H., Wilcoxen S.E., Phare S.M., Moore B.B., et al. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L1210-L1218
47. Pettit A.R., Ji H., von Stechow D., Muller R., Goldring S.R., Choi Y., et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 159 (2001) 1689-1699
48. Pfeilschifter J., Seyedin S.M., and Mundy G.R. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82 (1988) 680-685
49. Quinn J.M., Elliott J., Gillespie M.T., and Martin T.J. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139 (1998) 4424-4427
50. Quinn J.M., Itoh K., Udagawa N., Hausler K., Yasuda H., Shima N., et al. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J. Bone Miner. Res. 16 (2001) 1787-1794
51. Quinn J.M., Whitty G.A., Byrne R.J., Gillespie M.T., and Hamilton J.A. The generation of highly enriched osteoclast-lineage cell populations. Bone 30 (2002) 164-170
52. Redlich K., Hayer S., Ricci R., David J.P., Tohidast-Akrad M., Kollias G., et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110 (2002) 1419-1427
53. Rivollier A., Mazzorana M., Tebib J., Piperno M., Aitsiselmi T., Rabourdin-Combe C., et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104 (2004) 4029-4037
54. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 27 (1999) 1229-1241
55. Sells Galvin R.J., Gatlin C.L., Horn J.W., and Fuson T.R. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem. Biophys. Res. Commun. 265 (1999) 233-239
56. Stanley E., Lieschke G.J., Grail D., Metcalf D., Hodgson G., Gall J.A., et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5592-5596
57. Suda T., Tanaka S., and Takahashi N. Macrophage colony-stimulating factor (M-CSF) is essential for differentiation rather than proliferation of osteoclast progenitors. Osteoporos Int. 3 Suppl. 1 (1993) 111-113
58. Sudo T., Nishikawa S., Ogawa M., Kataoka H., Ohno N., Izawa A., et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 11 (1995) 2469-2476
59. Takahashi N., Udagawa N., Akatsu T., Tanaka H., Shionome M., and Suda T. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. (Off. J. Am. Soc. Bone Miner. Res.) 6 (1991) 977-985
60. Takahashi N., Yamana H., Yoshiki S., Roodman G., Mundy G., Jones S., et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122 (1988) 1373-1382
61. Takai H., Kanematsu M., Yano K., Tsuda E., Higashio K., Ikeda K., et al. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J. Biol. Chem. 273 (1998) 27091-27096
62. Takayanagi H., Kim S., Koga T., and Taniguchi T. Stat1-mediated cytoplasmic attenuation in osteoimmunology. J. Cell. Biochem. 94 (2005) 232-240
63. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 (2002) 744-749
64. Takeshita S., Kaji K., and Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15 (2000) 1477-1488
65. Tanaka S., Takahashi N., Udagawa N., Tamura T., Akatsu T., Stanley E.R., et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91 (1993) 257-263
66. Tinkler S.M., Linder J.E., Williams D.M., and Johnson N.W. Formation of osteoclasts from blood monocytes during 1 alpha-OH Vit D-stimulated bone resorption in mice. J. Anat. 133 (1981) 389-396
67. Verreck F.A., de Boer T., Langenberg D.M., Hoeve M.A., Kramer M., Vaisberg E., et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4560-4565
68. Walsh N.C., Crotti T.N., Goldring S.R., and Gravallese E.M. Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev. 208 (2005) 228-251
69. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186 (1997) 2075-2080
70. Yamazaki H., Kunisada T., Yamane T., and Hayashi S.I. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors. Exp. Hematol. 29 (2001) 68-76
71. Yan T., Riggs B.L., Boyle W.J., and Khosla S. Regulation of osteoclastogenesis and RANK expression by TGF-beta1. J. Cell. Biochem. 83 (2001) 320-325
72. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3597-3602
73. Zaidi M., Blair H.C., Moonga B.S., Abe E., and Huang C.L. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J. Bone Miner. Res. 18 (2003) 599-609
74. Zhou H., Choong P.C., Chou S.T., Kartsogiannis V., Martin T.J., and Ng K.W. Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits. Bone 17 (1995) 443S-448S